DXCM
Price:
$68.61
Market Cap:
$27.49B
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's p...[Read more]
Industry
Medical - Devices
IPO Date
2005-04-14
Stock Exchange
NASDAQ
Ticker
DXCM
According to DexCom, Inc.’s latest financial reports and current stock price. The company's current ROE is 29.58%. This represents a change of 292.82% compared to the average of 7.53% of the last 4 quarters.
The mean historical ROE of DexCom, Inc. over the last ten years is -0.87%. The current 29.58% ROE has changed -3488.34% with respect to the historical average. Over the past ten years (40 quarters), DXCM's ROE was at its highest in in the December 2020 quarter at 19.45%. The ROE was at its lowest in in the December 2018 quarter at -27.09%.
Average
-0.87%
Median
-2.55%
Minimum
-26.04%
Maximum
27.02%
Discovering the peaks and valleys of DexCom, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.92%
Maximum Annual ROE = 27.02%
Minimum Annual Increase = -159.78%
Minimum Annual ROE = -26.04%
Year | ROE | Change |
---|---|---|
2023 | 26.18% | 63.55% |
2022 | 16.01% | 132.94% |
2021 | 6.87% | -74.57% |
2020 | 27.02% | 135.92% |
2019 | 11.45% | -159.78% |
2018 | -19.16% | 60.09% |
2017 | -11.97% | -48.22% |
2016 | -23.11% | -11.23% |
2015 | -26.04% | 62.98% |
2014 | -15.98% | -54.91% |
The current ROE of DexCom, Inc. (DXCM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
16.35%
5-year avg
17.51%
10-year avg
-0.87%
DexCom, Inc.’s ROE is greater than Tandem Diabetes Care, Inc. (-49.43%), less than Inspire Medical Systems, Inc. (1.03%), less than ShockWave Medical, Inc. (24.79%), less than Penumbra, Inc. (1.22%), less than Insulet Corporation (50.53%), less than Integra LifeSciences Holdings Corporation (1.24%), greater than Senseonics Holdings, Inc. (-146.04%), less than Edwards Lifesciences Corporation (21.15%), less than InMode Ltd. (0%), less than Medtronic plc (19.39%), less than Abbott Laboratories (7.80%), less than Boston Scientific Corporation (14.41%), less than Zimmer Biomet Holdings, Inc. (9.30%), less than null (7.92%),
Company | ROE | Market cap |
---|---|---|
-49.43% | $2.78B | |
1.03% | $5.87B | |
24.79% | $12.57B | |
1.22% | $7.91B | |
50.53% | $15.06B | |
1.24% | $1.44B | |
-146.04% | $172.72M | |
21.15% | $40.25B | |
0% | $1.33B | |
19.39% | $115.28B | |
7.80% | $198.11B | |
14.41% | $120.17B | |
9.30% | $21.34B | |
7.92% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DexCom, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DexCom, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DexCom, Inc.'s ROE?
How is the ROE calculated for DexCom, Inc. (DXCM)?
What is the highest ROE for DexCom, Inc. (DXCM)?
What is the 3-year average ROE for DexCom, Inc. (DXCM)?
What is the 5-year average ROE for DexCom, Inc. (DXCM)?
How does the current ROE for DexCom, Inc. (DXCM) compare to its historical average?